Xconomy

SEPTEMBER 5, 2017

To that end, Kukutai’s venture capital firm, Finistere Ventures, is joining with the Ireland Strategic Investment Fund to launch a new 20 million euro ($24 million) fund that will invest in emerging agtech startups in Ireland. In addition to deals.

Invest 88

Invest Funding San Diego Venture Capital 88

socalTECH

DECEMBER 16, 2014

San Diego-based oncology drug developer Sorrento Therapeutics has scored a strategic investment from NantWorks , the biotech research company led by Dr. Patrick Soon-Shiong. The two said they will create a joint venture, funded with $20M, which will focus on developing immunotherapy antibodies. READ MORE>>.

Invest 147

Invest San Diego Venture Capital Research 147

socalTECH

APRIL 28, 2021

San Diego-based Boundless Bio, a company developing therapeutics for treating cancer, has raised $105M in its Series B funding, the company said this morning. The company said it will use the funding to support development of its multiple programs. As part of the funding, Jakob Loven, Ph.D.,

San Diego 113

San Diego Research Capital Invest 113

socalTECH

MARCH 29, 2021

San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.

Avalon 113

Avalon San Diego Research Funding 113

socalTECH

JANUARY 29, 2021

San Diego-based Encodia, a biotech company which is focused on proteomics research, has raised $75M in a Series C funding round, the company said this week. As part of the funding, Sharon Kedar of Northpond and Dr. Andrew ElBardissi of Deerfield Management have joined the company's board of directors.

San Diego 113

San Diego Research Capital Funding 113

socalTECH

JANUARY 19, 2016

San Diego-based life sciences maker Illumina has participated in another investment round for San Francisco-based DNA synthesis startup Twist Bioscience , in a new Series D funding for that company. Nick and Joby Pritzker (via Tao Invest), Paladin Capital Group, Yuri Milner, Boris Nikolic, plus others.

Invest 100

Invest San Diego Research Capital 100

socalTECH

NOVEMBER 10, 2020

San Diego-based biopharmaceuticals developer Ambrx has raised $200M in a funding round, according to the company, which included Fidelity Management & Research Company LLC, funds and accounts managed by BlackRock, Cormorant Asset Management, HBM Healthcare Investments, Invus, Adage Capital Partners and Suvretta Capital Management.

San Diego 113

San Diego Research Capital Invest 113

socalTECH

JULY 20, 2021

San Diego-based Wugen, a biotechnology company which is developing treatments for solid tumors, recently annoucned a $172M, Series B funding round. Venture Partner at ICG, will all join the company's board with the funding. Venture Partner at ICG, will all join the company's board with the funding.

San Diego 113

San Diego Capital Research Platform 113

socalTECH

FEBRUARY 23, 2011

San Diego-based Biomatrica , a developer of technology for storing biological samples at room temperature, announced this morning that it has scored an investment from In-Q-Tel, the investment arm of the U.S. Size of the funding was not announced. The funding came as part of a strategic partnership with In-Q-Tel.

Invest 160

Invest Sample San Diego Research 160

socalTECH

JULY 16, 2019

San Diego-based Trefoil Therapeutics , which is developing treatments for corneal diseases, has raised $28M in its Series A funding, the company said on Tuesday. As part of the funding, Bios Partners' co-founder Stella M. Robertson, Ph.D.,

San Diego 113

San Diego Research Funding Capital 113

socalTECH

SEPTEMBER 10, 2014

San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M in a Series B funding. The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments.

Avalon 147

Avalon San Diego Venture Capital Research 147

socalTECH

AUGUST 18, 2010

San Diego-based Anametrix , a developer of cloud-based business analytics software, said today that it has received new funding and added a slate of well known advisors. Details on the new private investment was not disclosed. Senturia is CEO of Blackbird Ventures, and a notable San Diego angel investor.

SEM 174

SEM Funding San Diego SaaS 174

Xconomy

MARCH 13, 2018

In the Boston office of GE Ventures, managing director Alex de Winter is overseeing investments in companies like Veracyte, which is applying machine learning to genomic sequencing technology to help doctors distinguish benign growths from cancer. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 67

San Diego Artificial Inteligence Research Invest 67

socalTECH

JANUARY 9, 2017

San Diego-based MatriSys Bioscience , which is developing treatments for treating skin and dermatologic conditions, says it has raised $1.5M in a funding round from the Tech Coast Angels. The lead investor in the investment was Jeff Friedman, MD, Ph.D., who is head of the TCA's Life Sciences Committee. READ MORE>>.

Tech Coast Angels 100

Tech Coast Angels Angel San Diego Research 100

socalTECH

JULY 30, 2014

San Diego-based Epic Sciences , a biotech startup focusing on diagnostics for treatment and management of cancer, has raised $30M in a Series C funding. The funding came from RusnanoMedInvest (RMI) and Arcus Ventures, plus Domain Associates, Roche Venture Fund, and Pfizer Venture Investments, as well as angels.

San Diego 138

San Diego Research Funding Invest 138

Xconomy

FEBRUARY 6, 2020

This is the last week to register at the lowest rate for March 18’s Xcelerating Life Sciences: Biomedical Breakthroughs in Precision Medicine & Genomics conference at the Takeda Research facility in San Diego. Hurry, our $99 early bird sale ends this Friday, Feb. 7 at midnight. Speakers include Jay Lichter, CEO of.

Conference 49

Conference San Diego Sales Research 49

socalTECH

SEPTEMBER 5, 2018

San Diego-based Gossamer Bio , the biopharmaceuticals firm which is focused on therapeutics in the autoimmune, allergy/inflammation and immuno-oncology disease areas, said today that it has named Luisa Salter-Cid, Ph.D. , Gossamer Bio said Salter-Cid will head up research and preclinical development efforts at the company.

San Diego 100

San Diego Research Funding Invest 100

Xconomy

OCTOBER 1, 2018

VelosBio, a biotech startup researching new cancer drugs, has raised $58 million in financing. VelosBio joined Johnson & Johnson’s JLABS @ San Diego incubator in January. The new VelosBio cash, a Series A round of financing, was led by Arix Bioscience (LSE: ARIX ) and Sofinnova Ventures.

San Diego 91

San Diego Incubator Class Study 91

Xconomy

JUNE 22, 2016

Radicle, a new accelerator fund focused on agricultural ventures, is launching today with plans to seed and nurture the next generation of agtech companies addressing global farming problems. Before making an investment, Radicle says it screens technologies and can quickly vet and validate technologies through its farm connections.

Funding 68

Funding Research San Diego Incubator 68

socalTECH

JUNE 9, 2015

San Diego-based life sciences equipment maker Illumina is the lead investor in San Francisco-based Twist Bioscience , a developer of a synthetic DNA manufacturing technology. Twist Bioscience said it raised $37M in a Series C, led by Illumina, and also included Fidelity Management and Research Company. in venture funding.

San Diego 100

San Diego Research Capital Invest 100

socalTECH

APRIL 4, 2011

San Diego-based AnaBios , a contract research organization focused on drug safety, said today that it has raised $800,000 as part of a Series A funding round. The funding was led by the Tech Coast Angels, including the Tech Coast Angels Angel Capital Entrepreneur (ACE) fund. AnaBios is headed by Dr. Jack A.

Tech Coast Angels 133

Tech Coast Angels San Diego Research Organization 133

socalTECH

NOVEMBER 13, 2012

San Diego-based Epic Sciences , a firm developing cancer diagnostics technology, announced today that it has raised $13M in a Series B equity round. The round came from Domain Associates, Roche Venture Fund, and Pfizer Venture Investments, along with individuals. READ MORE>>.

San Diego 138

San Diego Research Equity Platform 138

Xconomy

JUNE 27, 2018

Sales of Cibus’ first product, a gene-edited canola, have gone so well that the San Diego company has raised $70 million in new financing to boost its commercialization efforts.

San Diego 61

San Diego Marketing Research Invest 61

socalTECH

JUNE 18, 2012

San Diego-based SmartDrive Systems , which develops driving safety systems for managing driving fleets, said Monday afternoon that it has raised $47m in a new funding round. The firm said the round was led by Oak Investment Partners and New Enterprise Associates, and also included Stanford University. READ MORE>>.

Veoh 150

Veoh San Diego Research Funding 150

Xconomy

APRIL 15, 2020

Some of the targets in cancer research are visible and well known, but they’re hard to hit with new drugs all the same. PIC Therapeutics is developing medicines aiming for one particularly elusive group of proteins, and the startup’s early research has attracted financial support from some prominent names in the life sciences industry.

Research 91

Research Invest Funding Develop 91

socalTECH

MARCH 8, 2011

San Diego-based Sapphire Energy , a developer of algae-based biofuels technology, has scored an investment and deal with agricultural chemicals firm Monsanto , the two said this morning. Financial details of the investment were not disclosed. Sapphire has also scored $104.5M Sapphire has also scored $104.5M

San Diego 145

San Diego Equity Research Invest 145

Xconomy

APRIL 30, 2019

Vividion Therapeutics, a biotechnology company that launched in 2017 around discoveries made in Scripps Research Institute labs, has raised $82 million in financing. Nextech Invest, a Swiss investment firm that funds companies developing cancer therapeutics, led the Series B round of funding.

Research 87

Research Invest Funding Develop 87

Xconomy

MARCH 13, 2018

Crinetics Pharmaceuticals , a San Diego biotech focused on developing new drugs for endocrine disorders and endocrine-related cancers, said today it has raised $63.5 million in a Series B financing led by Perceptive Advisors, the New York biotech fund. In a statement Tuesday, Crinetics said it plans.

San Diego 49

San Diego Research Funding Capital 49

socalTECH

SEPTEMBER 21, 2011

San Diego-based MeLLmo , the developer of the Roambi mobile business apps, said today that it has launched a new iPad App, Roambi Flow. The firm--which is fresh off a $30M funding from Sequoia Capital--said the new software allows users to view "magazine-style" reports and publications on the iPad. READ MORE>>.

San Diego 140

San Diego Report Research Mobile 140

Xconomy

NOVEMBER 6, 2019

AstraZeneca says it will establish centers for drug research and artificial intelligence development in China. The pharmaceutical giant has also set up a $1 billion fund to foster biotech innovation in that country.

Artificial Inteligence 87

Artificial Inteligence Funding Research Sites 87

Xconomy

APRIL 10, 2020

The coronavirus research is expected. Startups are raising money, and there is more financing on the way as investment firms close new funds. The COVID-19 pandemic has stopped enrollment in many clinical trials and postponed the start of others but there is still life in the life sciences sector.

Activity 103

Activity Research Invest Startup 103

socalTECH

DECEMBER 30, 2016

Here, we have the thoughts of Jeb Spencer of TVC Capital (www.tvccapital.com), a software focused growth equity fund, and has had some great success in the market. Jeb Spencer: We closed our nineteenth and twentieth software focused growth equity investments this year, a significant milestone for our firm. READ MORE>>.

Capital 113

Capital Southern California Equity San Diego 113

Xconomy

FEBRUARY 15, 2017

For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego. Feldstein has been studying the liver for nearly 20 years, and his research now forms the basis of a newly launched company called Jecure Therapeutics.

UCSD 64

UCSD Press San Diego Class 64

Xconomy

SEPTEMBER 19, 2019

The San Diego-based biotech came out of stealth mode Thursday with an announcement that it had raised a $46.4 million Series A financing round to fund the development of cancer drugs targeting tumors that have what’s known as extrachromosomal DNA.

San Diego 102

San Diego Funding Develop Development 102

Xconomy

AUGUST 17, 2016

Histogen, a San Diego-based regenerative medicine company with technology for growing skin cells and related products, said it has raised $6 million from an affiliate of Huapont Life Sciences, a healthcare products company based in Chongqing, China.

Invest 40

Invest San Diego Journal Technical Review 40

TechCrunch LA

APRIL 8, 2021

In a small industrial park located nearly halfway between Los Angeles and San Diego, one company is claiming to have hit a milestone in the development of a new technology for generating power from nuclear fusion. Vulcan, Venrock, NEA, Wellcome Trust, Google, and the Kuwait Investment Authority are all backers.

Technology 354

Technology Artificial Inteligence Google Orange County 354

Xconomy

SEPTEMBER 5, 2018

Los Angeles has long been in San Francisco’s shadow when it comes to life sciences investment. But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital.

Westlake Village 73

Westlake Village Los Angeles Angel Venture Capital 73